Loading interface...

Levepsy 500 MG Tablet

Manufactured byCipla Ltd.
Description

Levepsy 500 MG Tablet is an anticonvulsant that is used to control seizures in adults and children. Take this medicine around the same time every day. Do not stop taking this medicine suddenly without informing the doctor as it may cause withdrawal symptoms.

Side effects

Major & minor side effects for Levepsy 500 MG Tablet

  • Aggression or anger
  • Anxiety
  • Headache
  • Shivering
  • Loss of appetite
  • Dizziness
  • Mood swings
  • Weakness
  • Double vision
  • Muscle pain
  • Body pain
  • Cough
  • Skin rash
  • Change in skin color

Uses of Levepsy 500 MG Tablet

What is it prescribed for?

  • Epilepsy
  • Seizures
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The time taken by this medicine to show its effect is not clinically established.
  • How long do the effects of this medicine last?
    The effect of this medicine lasts for an average of 18 to 24 hours.
  • Is it safe to consume alcohol while taking this medicine?
    Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of side effects such as dizziness, drowsiness, and difficulty in concentration. It is advised that you do not perform any activities that require high mental alertness like driving a vehicle or operating machinery during treatment with this medicine.
  • Is this a habit forming medicine?
    Habit-forming tendency has been reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless necessary. The risks and benefits should be discussed with the doctor before taking this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless necessary. The risks and benefits should be discussed with the doctor before taking this medicine.

Allergy

This medicine is not recommended for use if you are allergic to levetiracetam, pyrrolidone derivatives, or any other inactive ingredients present along with the formulation.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless necessary. The risks and benefits should be discussed with the doctor before taking this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless necessary. The risks and benefits should be discussed with the doctor before taking this medicine.
General warnings

Suicidal tendency

The use of this medicine may increase the risk of suicidal thoughts and behavioral changes. Close monitoring of signs of behavioral changes and suicidal thoughts is necessary while receiving this medicine. It should be used with caution and appropriate dose adjustments should be done in patients suffering from depression.

Blood cells count

This medicine may cause a decrease in blood cell count. Frequent monitoring of blood tests is to be performed and discontinue taking the medicine if Levitiracetam is suspected to be the cause.

Driving and operating machinery

The use of this medicine may cause tiredness, fatigue, drowsiness or dizziness in some patients. It is advised that you do not perform any activities such as driving a vehicle or operating machinery if you experience any of these symptoms during treatment with this medicine.

Hypersensitivity reactions

This medicine may cause allergic reactions including bronchospasm and angioedema in some patients. Appropriate corrective measures, dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Missed Dose

Take the missed dose as soon as you remember. If it’s almost time for your next dose, skip the missed dose. Do not double your dose to make up for the missed dose.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of side effects such as dizziness, drowsiness, and difficulty in concentration. It is advised that you do not perform any activities that require high mental alertness like driving a vehicle or operating machinery during treatment with this medicine.
Interaction with Medicine

Cetirizine

Opioids

Nortriptyline

Sodium oxybate

Disease interactions

Liver impairment

This medicine should be used with caution in patients with liver function impairment due to the increased risk of severe adverse effects. Close monitoring of liver function is recommended for such patients during treatment with this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Kidney impairment

This medicine should be used with caution in patients with kidney function impairment due to the increased risk of severe adverse effects. Close monitoring of kidney function is recommended for such patients during treatment with this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.
Food interactions
Information not available.
Lab interactions
Information not available.
Take this medicine with or without food. Do not take in larger amounts than advised. Consult the doctor if you experience any undesirable effects. Do not stop taking the medicine without consulting your doctor as it may cause withdrawal symptoms.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

Causes sleepiness

How it works
It works by binding to certain receptors in the brain and inhibits the excitation of brain cells.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Anticonvulsants

Schedule

Schedule H

[Internet]. 2017 [cited 9 March 2017]. Available from:

https://www.medicines.org.uk/emc/medicine/32704

Levetiracetam: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2017 [cited 9 March 2017]. Available from:

https://medlineplus.gov/druginfo/meds/a699059.html

DailyMed - Keppra- levetiracetam tablet [Internet]. Dailymed.nlm.nih.gov. 2017 [cited 24 October 2017]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fc0cbcd4-5400-4b71-a239-39e451b4c7b3

[Internet]. Medicines.org.uk. 2020 [cited 18 February 2020]. Available from:

https://www.medicines.org.uk/emc/files/pil.3073.pdf
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 6 Mar 2020

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.